| |
| |
|
| Insider
Information: |
Shlevin Harold H. |
| Relationship: |
Chief Executive Officer |
| City: |
Newton |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
8,706 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$29,078 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
8,706 |
|
|
| Total
Value |
$29,078 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Galectin Therapeutics Inc |
GALT |
Chief Executive Officer |
2019-06-04 |
8,706 |
2013-04-29 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| GALT |
Galectin Therapeutics Inc |
Chief Executive Officer |
• – – |
2019-06-04 |
4 |
OE |
$1.37 |
$11,927 |
D/D |
8,706 |
8,706 |
0 |
- |
|
| GALT |
Galectin Therapeutics Inc |
Chief Operating Officer |
• – – |
2018-06-13 |
4 |
AS |
$7.79 |
$240,916 |
D/D |
(30,918) |
0 |
0 |
- |
|
| GALT |
Galectin Therapeutics Inc |
Chief Operating Officer |
• – – |
2018-06-13 |
4 |
OE |
$0.00 |
$0 |
D/D |
25,544 |
30,918 |
0 |
- |
|
| GALT |
Galectin Therapeutics Inc |
Chief Operating Officer |
• – – |
2018-06-12 |
4 |
AS |
$6.50 |
$83,070 |
D/D |
(12,780) |
5,374 |
0 |
- |
|
| GALT |
Galectin Therapeutics Inc |
Chief Operating Officer |
• – – |
2018-06-11 |
4 |
AS |
$6.50 |
$69,940 |
D/D |
(10,760) |
18,154 |
0 |
- |
|
| GALT |
Galectin Therapeutics Inc |
Chief Operating Officer |
• – – |
2018-06-08 |
4 |
OE |
$0.87 |
$83,633 |
D/D |
79,294 |
184,099 |
0 |
- |
|
| GALT |
Galectin Therapeutics Inc |
Chief Operating Officer |
• – – |
2018-06-08 |
4 |
AS |
$5.77 |
$602,048 |
D/D |
(104,294) |
28,914 |
0 |
- |
|
| GALT |
Galectin Therapeutics Inc |
Chief Operating Officer |
• – – |
2018-06-07 |
4 |
AS |
$5.21 |
$525,269 |
D/D |
(100,891) |
53,914 |
0 |
- |
|
| GALT |
Galectin Therapeutics Inc |
Chief Operating Officer |
• – – |
2018-06-07 |
4 |
OE |
$0.87 |
$196,801 |
D/D |
100,891 |
154,805 |
0 |
- |
|
| GALT |
Galectin Therapeutics Inc |
Chief Operating Officer |
• – – |
2018-06-06 |
4 |
AS |
$5.15 |
$46,752 |
D/D |
(9,078) |
53,914 |
0 |
- |
|
| GALT |
Galectin Therapeutics Inc |
Chief Operating Officer |
• – – |
2018-06-06 |
4 |
OE |
$0.87 |
$13,959 |
D/D |
9,078 |
62,992 |
0 |
- |
|
| GALT |
Galectin Therapeutics Inc |
Chief Operating Officer |
• – – |
2018-06-05 |
4 |
AS |
$5.16 |
$51,183 |
D/D |
(9,924) |
53,914 |
0 |
- |
|
| GALT |
Galectin Therapeutics Inc |
Chief Operating Officer |
• – – |
2018-06-05 |
4 |
OE |
$0.87 |
$16,797 |
D/D |
9,924 |
69,338 |
0 |
- |
|
| GALT |
Galectin Therapeutics Inc |
Chief Operating Officer |
• – – |
2018-06-04 |
4 |
AS |
$5.15 |
$56,173 |
D/D |
(10,907) |
53,914 |
0 |
- |
|
| GALT |
Galectin Therapeutics Inc |
Chief Operating Officer |
• – – |
2018-06-04 |
4 |
OE |
$0.87 |
$17,464 |
D/D |
10,907 |
64,821 |
0 |
- |
|
| GALT |
Galectin Therapeutics Inc |
Chief Operating Officer |
• – – |
2018-06-01 |
4 |
AS |
$5.10 |
$352,920 |
D/D |
(69,200) |
53,914 |
0 |
- |
|
| GALT |
Galectin Therapeutics Inc |
Chief Operating Officer |
• – – |
2018-06-01 |
4 |
OE |
$0.87 |
$73,979 |
D/D |
69,200 |
123,114 |
0 |
- |
|
| GALT |
Galectin Therapeutics Inc |
Chief Operating Officer |
• – – |
2018-05-31 |
4 |
AS |
$5.00 |
$250,000 |
D/D |
(50,000) |
53,914 |
0 |
- |
|
| GALT |
Galectin Therapeutics Inc |
Chief Operating Officer |
• – – |
2018-05-31 |
4 |
OE |
$2.32 |
$116,000 |
D/D |
50,000 |
103,914 |
0 |
- |
|
| GALT |
Galectin Therapeutics Inc |
Chief Operating Officer |
• – – |
2014-04-16 |
4 |
D |
$0.00 |
$0 |
D/D |
(41,402) |
53,914 |
0 |
- |
|
| GALT |
Galectin Therapeutics Inc |
Chief Operating Officer |
• – – |
2014-01-10 |
4 |
D |
$13.49 |
$115,996 |
D/D |
(8,598) |
95,316 |
0 |
- |
|
| GALT |
Galectin Therapeutics Inc |
Chief Operating Officer |
• – – |
2014-01-10 |
4 |
OE |
$2.32 |
$116,000 |
D/D |
50,000 |
103,914 |
0 |
- |
|
| GALT |
Galectin Therapeutics Inc |
Chief Operating Officer |
• – – |
2013-11-18 |
4 |
B |
$6.63 |
$3,315 |
D/D |
500 |
53,914 |
2.66 |
- |
|
| GALT |
Galectin Therapeutics Inc |
Chief Operating Officer |
• – – |
2013-04-29 |
4 |
D |
$4.98 |
$231,998 |
D/D |
(46,586) |
53,414 |
0 |
- |
|
| GALT |
Galectin Therapeutics Inc |
Chief Operating Officer |
• – – |
2013-04-29 |
4 |
OE |
$2.32 |
$232,000 |
D/D |
100,000 |
100,000 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
